Clinics in dermatologyOct 10, 2026

Changes in Facial Appearance and Aging Linked to Ozempic Use

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗

Updated Oct 11, 2026

Abstract

Rapid weight loss associated with GLP-1 receptor agonists may lead to accelerated facial aging, known as 'Ozempic face'.

Facial changes include volume deflation, skin laxity, and loss of structural support.
The review highlights the roles of dermal white adipose tissue, skeletal remodeling, and muscle loss in these changes.
A practical framework for assessing and counseling patients undergoing weight loss is presented.
Timing and sequencing of interventions are important for minimizing tissue loss during weight loss.
Dermatology clinicians may play a key role in managing aesthetic concerns related to weight loss from these medications.

Simplified

The widespread adoption of glucagon-like peptide-1 (GLP-1) receptor agonists has introduced a growing clinical challenge for dermatologists and cosmetic practitioners: managing the facial changes associated with rapid weight loss. The term "Ozempic face" has entered popular vocabulary to describe the appearance of accelerated facial aging in patients on these medications, characterized by volume deflation, skin laxity, and loss of structural support. This review examines the anatomical and histological basis of these changes, with attention to the roles of dermal white adipose tissue (dWAT), skeletal remodeling, and sarcopenia. We discuss the clinical presentation of weight-loss-associated facial change and outline a practical framework for patient assessment and counseling. The timing and sequencing of interventions across the weight loss journey are addressed, with emphasis on a health-first approach that prioritizes tissue preservation. As GLP-1 receptor agonists expand into new therapeutic indications, including inflammatory skin diseases, dermatology clinicians are uniquely positioned to counsel and manage patients experiencing these changes.

Full Text

Full text is available at the source.

View Full Text ↗

Changes in Facial Appearance and Aging Linked to Ozempic Use

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the glp-1 therapies brief